Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Besifovir and L-carnitine in chronic hepatitis B patients with fatty liver
KCT0008032Phase 4Completed
- Sponsor
- Ildong Pharmaceutical Co Ltd
- Start
- Nov 2019
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of besifovir dipivoxil maleate, levocarnitine in Chronic Hepatitis B (CHB), steatosis, sponsored by Ildong Pharmaceutical Co Ltd. Started Nov 2019; status: completed.
02
Drugs
besifovir dipivoxil maleatelevocarnitine
03
Conditions
Chronic Hepatitis B (CHB)steatosis
Beyond the preview
Go deeper on KCT0008032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0008032.